These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 17966605
1. [The effect of substitution therapy on the birth weight of the newborn, its postpartum adaptation, trophic and course of the neonatal abstinence syndrome]. Vavrinková B, Binder T. Ceska Gynekol; 2007 Aug; 72(4):247-53. PubMed ID: 17966605 [Abstract] [Full Text] [Related]
2. Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Binder T, Vavrinková B. Neuro Endocrinol Lett; 2008 Feb; 29(1):80-6. PubMed ID: 18283247 [Abstract] [Full Text] [Related]
3. [Socioeconomic datas, the course of pregnancy and delivery in opioid-addicted women and women under substitution therapy]. Vavrinková B, Binder T. Ceska Gynekol; 2007 Oct; 72(5):330-5. PubMed ID: 18175516 [Abstract] [Full Text] [Related]
7. Use of naltrexone in treating opioid use disorder in pregnancy. Towers CV, Katz E, Weitz B, Visconti K. Am J Obstet Gynecol; 2020 Jan 23; 222(1):83.e1-83.e8. PubMed ID: 31376396 [Abstract] [Full Text] [Related]
12. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack. Heidebrecht F, MacLeod MB, Dawkins L. Addict Behav; 2018 Feb 23; 77():210-216. PubMed ID: 29065377 [Abstract] [Full Text] [Related]
14. The management of heroin misuse in pregnancy: time for a rethink? Mactier H. Arch Dis Child Fetal Neonatal Ed; 2011 Nov 23; 96(6):F457-60. PubMed ID: 20584799 [Abstract] [Full Text] [Related]
16. [Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases]. Lejeune C, Aubisson S, Simmat-Durand L, Cneude F, Piquet M, Gourarier L, Groupe d'Etudes Grossesse et addictions. Ann Med Interne (Paris); 2001 Nov 23; 152 Suppl 7():21-7. PubMed ID: 11965095 [Abstract] [Full Text] [Related]
17. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Nechanská B, Mravčík V, Skurtveit S, Lund IO, Gabrhelík R, Engeland A, Handal M. Addiction; 2018 Jul 23; 113(7):1286-1294. PubMed ID: 29443414 [Abstract] [Full Text] [Related]
19. Predictors of neonatal outcomes amongst a methadone- and/or heroin-dependent population referred to a multidisciplinary Perinatal and Family Drug Health Service. Buckley V, Razaghi A, Haber P. Aust N Z J Obstet Gynaecol; 2013 Oct 23; 53(5):464-70. PubMed ID: 23550533 [Abstract] [Full Text] [Related]
20. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014. Brogly SB, Turner S, Lajkosz K, Davies G, Newman A, Johnson A, Dow K. J Obstet Gynaecol Can; 2017 Mar 23; 39(3):157-165. PubMed ID: 28343557 [Abstract] [Full Text] [Related] Page: [Next] [New Search]